SCHEMBL7515527

SCHEMBL7515527

CCc1c(O)nc(C)nc1C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 3/20 0.38
EGLN1 Q9GZT9 4/20 0.37
RXRA P19793 2/20 0.35
NR4A2 P43354 2/20 0.35
PDE4B Q07343 1/20 0.35
PDE4D Q08499 1/20 0.35
ALDH1A1 P00352 2/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
NPC1 O15118 1/20 0.31
KDM4E B2RXH2 1/20 0.30
ATM Q13315 1/20 0.30
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
PABPC1 P11940 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1706091 0.80 CYP1A2 (0.41) ALDH1A1CYP1A2KDM4E
SCHEMBL7519075 0.79 TDP1 (0.39) HCAR2EGLN1RXRANR4A2PDE4B
SCHEMBL2743303 0.75 EGLN1 (0.37) HCAR2EGLN1ALDH1A1KDM4EPOLB
SCHEMBL4913697 0.75 EGLN1 (0.41) HCAR2EGLN1ALDH1A1
SCHEMBL5188179 0.75 HCAR2 (0.41) HCAR2RXRANR4A2PDE4BPDE4D
SCHEMBL10776031 0.75 TSHR (0.41) HCAR2ALDH1A1LMNACYP2C9ATM
SCHEMBL7824207 0.72 HCAR2 (0.42) HCAR2EGLN1ALDH1A1KDM4E
SCHEMBL31751932 0.69 TDP1 (0.44) HCAR2RXRANR4A2PDE4BPDE4D
SCHEMBL6298416 0.69 HCAR2 (0.40) HCAR2RXRANR4A2PDE4BPDE4D
SCHEMBL5477906 0.69 ALDH1A1 (0.40) HCAR2EGLN1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863882-B1 AMINO SUBSTITUTED PYRIMIDINES AND TRIAZINES JANSSEN PHARMACEUTICA NV (BE) 2002-02-06 EP disclosed
US-6288060-B1 CORTICOTROPIN RELEASING FACTOR ANTAGONISTS; ANXIOLYTIC, ANTIDEPRESSANT, ANTIINFLAMMATORY AGENTS; EATING DISORDERS NEUROCRINE BIOSCIENCES, INC. 2001-09-11 US disclosed